Aspire Biopharma Buys Auto Parts Giant to Diversify Revenue

New York, Monday, 10 August 2026.
On August 10, 2026, Aspire Biopharma completed its $30 million acquisition of Dura Driver Control Systems. The deal allows a biotech firm to absorb a century-old auto supplier generating over $200 million in annual revenue, instantly shifting its operational scale and cash flow potential.